- By ICR Secretariat
- Posted Monday, June 27, 2022
NICE recommends Eli Lilly’s breast cancer therapy
https://www.pharmatimes.com/news/nice_recommends_eli_lillys_breast_cancer_therapy_1450121
Verzenios in combination with endocrine treats people with early breast cancer who are at high-risk of recurrence
The oldest independent membership-led professional body for clinical researchers across the globe.
Latest Posts
- NICE recommendation expands patient eligibility for AbbVie’s Ozurdex 18/08/2022 03:38 PM
- Amgen’s low tax rates draw attention of top Democratic senator 18/08/2022 03:23 PM
- 2 deaths after Novartis' Zolgensma put gene therapy's liver safety in the spotlight once again 18/08/2022 03:16 PM
Useful Links
Contact Us
Suite 11a, Cedar Court
Grove Park
White Waltham
Maidenhead
SL6 3LW
info@icr-global.org